Hepatocellular carcinoma (HCC) constitutes a difficult health challenge because of its poor
prognosis and limited treatment options. Most available therapies are used only for …

Administration of yttrium‐90 microspheres via the hepatic artery is an attractive approach to
selectively deliver therapeutic doses of radiation to liver malignancies. This procedure …

PURPOSE: This article reviews the role of selective internal irradiation (SIR) with yttrium-90
(90Y) microspheres for hepatocellular carcinoma (HCC). METHODS AND MATERIALS …

Methods. Ten patients with primary hepatocellular carcinoma were treated with intraarterial
instillation of yttrium‐90 (Y‐90) microspheres, including eight men and two women (median …

PURPOSE: Intraarterial injection of yttrium 90 microspheres (TheraSpheres) is used in the
treatment of hepatocellular carcinoma (HCC). This article presents an analysis of the …

Management of hepatic malignancies is a ubiquitous medical problem. Surgical resection of
primary or metastatic liver cancer, with or without adjuvant chemotherapy, is the most …

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) has limited treatment options;
long-term outcomes following intra-arterial radiation are unknown. We assessed clinical …

ABSTRACT Yttrium-90 (90 Y) radioembolization is a catheter-based therapy that delivers
internal radiation to hepatic tumors in the form of microspheres. 90 Y can be delivered to the …

The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive
techniques positively influence the outcome of disease progression in these patients …

Treatment for nonresectable hepatocellular carcinoma (HCC) is palliative. The relatively
greater arteriolar density of hepatic tumors compared with normal liver suggests that …